BR112017023750A2 - desintoxicação de fatores de virulência microbiana na cavidade bucal - Google Patents

desintoxicação de fatores de virulência microbiana na cavidade bucal

Info

Publication number
BR112017023750A2
BR112017023750A2 BR112017023750A BR112017023750A BR112017023750A2 BR 112017023750 A2 BR112017023750 A2 BR 112017023750A2 BR 112017023750 A BR112017023750 A BR 112017023750A BR 112017023750 A BR112017023750 A BR 112017023750A BR 112017023750 A2 BR112017023750 A2 BR 112017023750A2
Authority
BR
Brazil
Prior art keywords
detoxification
virulence factors
oral cavity
microbial virulence
microbial
Prior art date
Application number
BR112017023750A
Other languages
English (en)
Inventor
Sue Tansky Cheryl
James White Donald
Christian Haught John
Xie Sancai
Glenn Huggins Thomas
Vinod Mantri Yogita
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR112017023750A2 publication Critical patent/BR112017023750A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0204—Specific forms not provided for by any of groups A61K8/0208 - A61K8/14
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A61K8/21—Fluorides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/579—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving limulus lysate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/50—Lipopolysaccharides; LPS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Physiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

a invenção se refere a um método para identificar constituintes para desintoxicar fatores de virulência oral e a um método para determinar a eficácia de agentes de desintoxicação.
BR112017023750A 2015-05-06 2016-05-06 desintoxicação de fatores de virulência microbiana na cavidade bucal BR112017023750A2 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562157671P 2015-05-06 2015-05-06
US201562157659P 2015-05-06 2015-05-06
US201662309110P 2016-03-16 2016-03-16
PCT/US2016/031350 WO2016179561A1 (en) 2015-05-06 2016-05-06 Detoxification of microbial virulence factors in oral cavity

Publications (1)

Publication Number Publication Date
BR112017023750A2 true BR112017023750A2 (pt) 2018-07-31

Family

ID=56024418

Family Applications (2)

Application Number Title Priority Date Filing Date
BR112017023750A BR112017023750A2 (pt) 2015-05-06 2016-05-06 desintoxicação de fatores de virulência microbiana na cavidade bucal
BR112017023726A BR112017023726A2 (pt) 2015-05-06 2016-05-06 detecção de fatores de virulência microbiana na cavidade oral

Family Applications After (1)

Application Number Title Priority Date Filing Date
BR112017023726A BR112017023726A2 (pt) 2015-05-06 2016-05-06 detecção de fatores de virulência microbiana na cavidade oral

Country Status (8)

Country Link
US (3) US10156566B2 (pt)
EP (2) EP3292215A1 (pt)
CN (2) CN107636464B (pt)
AU (2) AU2016258194B2 (pt)
BR (2) BR112017023750A2 (pt)
CA (2) CA2983629A1 (pt)
MX (2) MX2017014198A (pt)
WO (2) WO2016179561A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2017014198A (es) 2015-05-06 2018-06-28 Procter & Gamble Desintoxicacion de los factores de virulencia microbiana en la cavidad oral.
US9964472B2 (en) 2016-06-29 2018-05-08 The Procter & Gamble Company Methods for sampling gingival metabolites
CN107189986B (zh) * 2017-07-25 2020-08-11 南京大学 一种基于内质网应激的报告基因细胞株构建方法及其应用
CN111077307B (zh) * 2018-10-21 2022-08-23 厦门鲎试剂生物科技股份有限公司 一种用革兰氏阴性细菌感染快速检测脓毒病的新方法
EP4018196A1 (en) * 2020-04-02 2022-06-29 Colgate-Palmolive Company Compositions for and methods of neutralizing lipopolysaccharide toxicity and methods of identifying the same
US20230400459A1 (en) * 2022-06-09 2023-12-14 Hero Scientific Ltd. Gargle specimen sampling
CN115368430B (zh) * 2022-09-02 2024-02-02 北京化工大学 一种雷公藤红素金属络合物的制备方法和应用
WO2024102226A1 (en) * 2022-10-14 2024-05-16 Evelo Biosciences, Inc. Methods for assaying drug substances and drug products by using cell lines with nf-kb- inducible reporter genes

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175089A (en) 1988-07-15 1992-12-29 The Trustees Of Columbia University In The City Of New York Method for monitoring periodontal disease by monitoring endotoxins and inflammatory agents
CA2323630A1 (en) 1989-02-14 1990-08-15 Invitron Corporation Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat lipopolysaccharide associated gram negative infections
ATE355380T1 (de) * 1993-04-02 2006-03-15 Rigel Pharmaceuticals Inc Methode zur selektiven inaktivierung der viralen replication
CA2176237A1 (en) 1993-11-10 1995-05-18 Richard P. Darveau Treatment of bacterially-induced inflammatory diseases
US20040258630A1 (en) * 2003-06-23 2004-12-23 Boyd Thomas J. Antiplaque breath freshening consumable film
US8414293B2 (en) * 2005-06-28 2013-04-09 Colgate-Palmolive Company Carrier strip for application to oral surfaces and related methods
BRPI0613515A2 (pt) 2005-07-11 2011-01-11 Cbio Ltd imunomodulação induzida por chaperonina 10
PL1971865T3 (pl) 2006-01-10 2014-02-28 Colgate Palmolive Co Sposoby modulowania powierzchniowych receptorów komórek w celu zapobiegania zapaleniu lub jego zmniejszania
US8147807B2 (en) * 2006-07-20 2012-04-03 National University Corporation Okayama University Oral composition for dental purposes
CN105213247A (zh) * 2006-09-29 2016-01-06 宝洁公司 包含凝胶网络的口腔组合物
AU2008238445B2 (en) * 2007-04-13 2012-02-02 V-Biotek Holding Aps Extract of Trigonella foenum-graecum
US20120019735A1 (en) 2009-03-25 2012-01-26 Koninklijke Philips Electronics N.V. Liquid crystal cell manufacture
AU2011207441A1 (en) * 2010-01-22 2012-08-09 The Trustees Of The University Of Pennsylvania Methods of treating or preventing periodontitis and diseases associated with periodontitis
GB2481267B (en) * 2010-06-15 2016-04-20 Univ Leicester Assay for determining the risk of a toll-like receptor containing foodstuff for causing systemic inflammation in vivo
BR112015014966A2 (pt) 2012-12-20 2017-07-11 Colgate Palmolive Co composição de cuidado oral contendo líquidos iônicos
MX2017014198A (es) 2015-05-06 2018-06-28 Procter & Gamble Desintoxicacion de los factores de virulencia microbiana en la cavidad oral.

Also Published As

Publication number Publication date
WO2016179560A1 (en) 2016-11-10
US20160327557A1 (en) 2016-11-10
AU2016258194A1 (en) 2017-11-30
CN107636464B (zh) 2020-08-11
US9970934B2 (en) 2018-05-15
EP3292215A1 (en) 2018-03-14
AU2016258194B2 (en) 2019-01-03
CN107636464A (zh) 2018-01-26
CA2983625C (en) 2020-11-24
MX2017014196A (es) 2018-03-01
AU2016258195A1 (en) 2017-11-30
CN107567587B (zh) 2020-10-16
WO2016179561A1 (en) 2016-11-10
BR112017023726A2 (pt) 2018-07-31
US10267797B2 (en) 2019-04-23
CA2983625A1 (en) 2016-11-10
AU2016258195B2 (en) 2019-07-04
EP3292216A1 (en) 2018-03-14
US20180231546A1 (en) 2018-08-16
MX2017014198A (es) 2018-06-28
US20170119643A1 (en) 2017-05-04
CA2983629A1 (en) 2016-11-10
US10156566B2 (en) 2018-12-18
CN107567587A (zh) 2018-01-09

Similar Documents

Publication Publication Date Title
BR112017023750A2 (pt) desintoxicação de fatores de virulência microbiana na cavidade bucal
DOP2017000271A (es) Métodos de acondicionamiento de pacientes para tratamiento con linfocitos t
CL2018002359A1 (es) Métodos para usar agonistas de fxr
DOP2017000272A (es) Métodos de diagnóstico para tratamiento con linfocitos t
MD3313421T2 (ro) Compoziții cuprinzând o tulpină bacteriană de Blautia hydrogenotrophica pentru utilizare în tratamentul infecțiilor bacteriene ale tractului gastrointestinal
MA41212A (fr) Composition de soin oral contenant des cannabinoïdes
EA201790398A1 (ru) Способы лечения заболевания печени
BR112016017418A2 (pt) Uso de copolímeros
AR092330A1 (es) Composiciones, metodos de absorcion transmucosa y metodo de tratamiento
PE20180260A1 (es) Metodos y kits para tratar la depresion
UY34328A (es) ?composiciones y métodos para controlar malezas comprendiendo un polinucleótido y agente de transferencia, y que modulan protoporfirinógeno ix oxidasa?.
BR112017003578A2 (pt) kit para radiomarcação com 68ga compreendendo um inibidor de metal
MX2018016057A (es) Composiciones y metodos para tratar enfermedades cardiovasculares.
EA202090683A3 (ru) Способы и композиции для лечения рака
AR101312A1 (es) Combinaciones de inhibidores de bet e inhibidores de tirosina quinasa de bruton
EA201790787A1 (ru) Снижение вязкости фармацевтических составов
AR100436A1 (es) Método y dispositivo para medir la permeabilidad de la dentina
DK3608425T3 (da) Hcbi, msbi, mssi og cmi sekvenser som en tidlig markør for den fremtidige udvikling af cancer og sygdomme i cns og som mål for behandling og forebyggelse af disse sygdom-me
BR112017000199A2 (pt) composição adjuvante que compreende cloreto de colina ou fosfato de potássio (dibásico como um inibidor de hidratação)
BR112014012623A2 (pt) métodos para determinar adequação de terapia anticâncer, composição, kit e método para melhorar o efeito do tratamento de um regime quimioterápico
EA201692534A1 (ru) Способы лечения гипотонии
DK3319643T3 (da) HBED-bisphosphonater og radiometalkonjugater deraf, anvendelige som theranostiske midler
ECSP16058769A (es) Composicion para la administracion oral de agente bioactivos
BR112018013189A2 (pt) zaragatoa para amostragem bucal e usos da mesma
PE20150020A1 (es) Sistemas y metodos para tratar una respuesta farmacodinamica adversa inducida por opioides

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2669 DE 03-03-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.